COVID Vaccine and Infertility: A Closer Look at Fertility

COVID-19 vaccines do not cause infertility. That finding holds across every major fertility measure researchers have tested: ovarian reserve markers, sperm quality, time to pregnancy, IVF success rates, and pregnancy outcomes including miscarriage and stillbirth. The concern, which spread widely in late 2020 and early 2021, grew from a biological hypothesis that turned out to be wrong. But the volume of research that followed has done more than debunk a myth; it has built one of the most thoroughly studied vaccine-fertility datasets in modern medicine.

Where the Infertility Fear Came From

The worry centered on a protein called syncytin-1, which plays a role in placental development. The hypothesis, circulated online and in a widely shared petition, claimed that the spike protein produced by mRNA vaccines looked similar enough to syncytin-1 that the immune system would learn to attack it, disrupting implantation and pregnancy. The idea sounded alarming but had a testable prediction: vaccinated people should develop antibodies against syncytin-1.

Multiple research groups tested this directly. A study published in PLOS Biology found no increased levels of circulating anti-syncytin-1 antibodies in vaccinated adults compared with unvaccinated adults.¹ A separate study of people who received the Pfizer vaccine, including two pregnant women, confirmed the same result: strong neutralizing activity against SARS-CoV-2, but no placental anti-syncytin-1 binding antibodies at any time point after vaccination.² The structural similarity between the spike protein and syncytin-1 is too small to trigger cross-reactive immune responses. The hypothesis failed its own test.

Ovarian Reserve After Vaccination

Anti-Müllerian hormone, or AMH, is the standard blood marker clinicians use to estimate a woman’s remaining egg supply. If COVID vaccines harmed ovarian function, AMH levels would drop after vaccination. Researchers checked this in detail.

A study published in Human Reproduction followed women before and three months after mRNA vaccination. AMH levels were essentially unchanged: the average was 5.3 µg/l at baseline and 5.3 µg/l afterward, with no significant difference across age groups younger than 30, 30 to 35, or older than 35.³ The strength of a woman’s immune response to the vaccine had no bearing on her AMH levels, either. A later systematic review and meta-analysis pooling multiple studies confirmed this pattern: the overall change in AMH after vaccination was not statistically significant.⁴ Vaccination simply does not appear to affect the egg supply.

Semen Quality Before and After Vaccination

The picture for male fertility is slightly more nuanced but reaches the same bottom line. A study published in JAMA measured semen parameters in men before and after their second dose of the Pfizer or Moderna vaccine. Sperm concentration, total motile count, volume, and motility all significantly increased after vaccination.⁵ That does not mean vaccination improves sperm; the increase likely reflects normal biological variation and the relatively small sample. But it clearly shows no damage.

One Israeli study of semen donors did find a temporary dip. Sperm concentration dropped by about 15% and total motile count by about 22% roughly three to four months after vaccination, compared with baseline. But by the next measurement window, values had fully recovered.⁶ A study of an inactivated vaccine found no statistically significant changes in any semen parameter at all.⁷ Meta-analyses pooling studies of different vaccine types found no significant differences in sperm concentration, progressive motility, or semen volume between pre- and post-vaccination samples.⁸

The temporary dip seen in the donor study is consistent with what any short-lived fever or immune activation can do. Sperm production is sensitive to body temperature and systemic inflammation, and about 16% of men in the Pfizer clinical trial reported fever after the second dose.⁹ Since the sperm production cycle runs roughly 74 days, a brief immune response would be expected to cause a short window of lower counts, followed by full recovery. That pattern is exactly what was observed.

The Infection Itself Is a Bigger Threat Than the Vaccine

One of the most underappreciated findings in this area is that COVID-19 infection poses a real risk to male reproductive health, while vaccination does not. A review in Medical Science Monitor noted that published data show decreased sperm quality and orchitis (inflammation of the testes) in men with COVID-19, including reduced sperm count, decreased motility, and elevated DNA fragmentation. By contrast, the same review found no evidence that any SARS-CoV-2 vaccine has pathological effects on spermatogenesis or male reproductive health.¹⁰ In other words, the vaccine protects against the very thing some people feared it would cause.

Menstrual Cycle Changes Are Real but Small

Menstrual changes after COVID vaccination are the one reproductive effect that has been consistently documented, and ignoring it would be dishonest. Many women reported heavier or irregular periods after their shots, and the research confirms a real signal, albeit a modest and temporary one.

A large retrospective cohort study using prospectively tracked cycle data from a global population found that vaccinated individuals experienced a less-than-one-day increase in cycle length after each dose, compared with unvaccinated individuals. Menses length itself was unaffected.¹¹ A prospective cohort study found a similar pattern: cycles were about one day longer after the first dose and about 1.3 days longer after the second dose, with the effect fading by the second post-vaccination cycle. Bleed length, heaviness, regularity, and pain were not meaningfully affected.¹²

A systematic review of 14 studies covering over 78,000 vaccinated women found wide variation in reported menstrual problems, ranging from less than 1% to over 90% depending on the study, with heavier-than-usual bleeding being the most common complaint. The review also noted that age, pregnancy history, systemic side effects of the vaccine, and receiving a second dose were all associated with a higher likelihood of menstrual disturbance.¹³ That enormous range across studies reflects differences in how menstrual problems were defined and collected, not genuine differences in biology. The better-designed prospective studies, which tracked cycles before and after vaccination using apps or standardized questionnaires, consistently converge on a roughly one-day temporary shift in cycle length.

This matters for how you interpret your own experience. If your period arrived a day or two late after your vaccine, that fits the data. If your period was noticeably heavier for one cycle, you are not alone. But neither of these effects signals any lasting change to fertility or reproductive function.

Time to Pregnancy for Couples Trying to Conceive

The most directly reassuring evidence for couples planning a family comes from the PRESTO study, a large prospective cohort study that followed couples actively trying to conceive through intercourse. Vaccination in either partner had no meaningful association with the probability of conceiving in any given cycle. Women who received at least one dose had a fecundability ratio of 1.08, meaning they were just as likely to conceive as unvaccinated women. For male partners, the ratio was 0.95 for at least one dose and 1.00 for a full vaccine regimen. Couples where both partners were vaccinated had a fecundability ratio of 0.97, statistically indistinguishable from couples where neither was vaccinated.¹⁴ Time to pregnancy was essentially the same regardless of vaccination status.

IVF and Assisted Reproduction Outcomes

For people undergoing IVF or similar treatments, the data is reassuring overall, with one wrinkle worth knowing about. A systematic review and meta-analysis found no significant differences in biochemical or clinical pregnancy rates between vaccinated and unvaccinated groups.⁸ A study comparing multiple vaccine types found that neither mRNA nor adenoviral-vector vaccines affected ovarian stimulation results or IVF outcomes.¹⁵

The wrinkle relates to timing. A study published in JAMA Network Open found that women who began IVF within 30 days of vaccination had a lower ongoing pregnancy rate compared with unvaccinated women (about 34% versus 60%). That gap narrowed as the interval increased and effectively disappeared by 91 days or more after vaccination.¹⁶ This does not prove the vaccine harmed fertility; the acute immune response may temporarily alter the uterine environment in a way that affects implantation of fresh embryos. The practical takeaway for anyone scheduling IVF is straightforward: if you can space your vaccination and your embryo transfer by a few months, the data suggest no difference at all.

A study specifically examining oocytes exposed to the vaccine’s lipid nanoparticles in vivo found that embryos produced from those oocytes were not less likely to result in pregnancy or more likely to miscarry.¹⁷

Miscarriage and Early Pregnancy

The fear that vaccination during early pregnancy might trigger miscarriage was one of the most emotionally charged concerns. The evidence strongly argues against it. A systematic review and meta-analysis of 18 studies, covering over 123,000 pregnancies, found that the overall miscarriage rate among vaccinated women was about 9%, and vaccinated women did not have a higher risk of miscarriage compared with those who received a placebo or no vaccination. Rates of ongoing pregnancy and live birth were comparable.¹⁸ For context, the background miscarriage rate in the general population is typically estimated at 10 to 20%, so 9% among vaccinated women falls within or even below the expected range.

A population-based matched cohort study from Scotland found no association between vaccination and miscarriage (adjusted odds ratio of 1.02) or ectopic pregnancy (adjusted odds ratio of 1.13, not statistically significant).¹⁹ These are large, well-designed studies, and they all converge on the same answer.

Later Pregnancy, Stillbirth, and Neonatal Health

The data on later pregnancy is not just neutral; it points toward a protective effect. A multicenter cohort study found that vaccinated women had significantly lower rates of stillbirth (0.2% versus 0.8% for unvaccinated women) and lower rates of preterm birth at less than 37 weeks (5.1% versus 9.2%). Infants born to vaccinated mothers were also less likely to need neonatal intensive care.²⁰

A large two-country meta-analysis published in JAMA confirmed these findings. Infants exposed to the vaccine during pregnancy were less likely to be born preterm, less likely to be small for gestational age, and had lower rates of neonatal mortality. Vaccination was also associated with lower odds of nontraumatic intracranial hemorrhage in newborns.²¹ These benefits are likely tied to the vaccine’s ability to prevent severe COVID infection during pregnancy, which is itself a known risk factor for preterm delivery and stillbirth.

What Happens at the Placenta

Placental studies offer a window into why vaccination during pregnancy appears protective. A histopathology study comparing placentas from vaccinated and unvaccinated women who tested positive for COVID-19 found that SARS-CoV-2 was only detected in placental tissue from unvaccinated mothers. The risk of fetal death was more than five times higher in unvaccinated mothers, and their placentas showed significantly more damage, including syncytiotrophoblast necrosis and chronic inflammation.²²

Another placental study found that while most placentas from COVID-positive women showed some microscopic abnormalities regardless of vaccination status, certain lesions linked to vascular supply problems were actually less common in vaccinated mothers. The vaccine appeared to have a protective effect against specific types of placental damage, including focal fibrin deposits and avascular fibrotic villi.²³

What Preclinical Safety Testing Showed

Before any COVID vaccine reached a human arm, standard reproductive toxicology studies were conducted in animals. These followed internationally recognized regulatory guidelines and looked at mating, fertility, embryo development, fetal anatomy, postnatal growth, and even neurodevelopmental outcomes in offspring.

The Pfizer-BioNTech mRNA vaccine was tested in rats at doses more than 300 times the human dose on a per-kilogram basis. There were no effects on female mating performance, fertility, or any ovarian or uterine parameters, and no adverse effects on embryo survival, fetal growth, physical development, or brain function in offspring. Vaccinated mothers produced neutralizing antibodies that transferred to their fetuses and pups through the placenta and breast milk.²⁴ Similarly clean results were seen in studies of a recombinant protein subunit vaccine and an adenoviral-vector vaccine, both tested across full reproductive cycles in rats with no treatment-related malformations or developmental harm.²⁵²⁶

Does the Vaccine Type Matter

Several different COVID vaccine platforms have been studied for fertility effects: mRNA (Pfizer, Moderna), adenoviral vector (AstraZeneca, Johnson & Johnson, Sputnik V), inactivated virus (Sinopharm, Sinovac), and protein subunit vaccines. Across all of them, the overall conclusion is the same.

A study of 510 IVF patients who received different vaccine types found no differences in reproductive outcomes or treatment results between those vaccinated with adenoviral-vector vaccines and those vaccinated with mRNA vaccines, and no differences between either vaccinated group and unvaccinated controls.¹⁵ A meta-analysis that performed subgroup analyses by vaccine type found no significant differences in biochemical pregnancy rates for mRNA vaccines, and no changes in testosterone, FSH, or LH levels for the Sputnik V vaccine.⁸ Studies of semen parameters after mRNA versus viral-vector vaccines also found equivalent results.²⁷ Whatever your vaccine platform, the fertility evidence is consistent.

Vaccine Hesitancy and the Fertility Treatment Experience

Understanding why infertility concerns persisted despite the evidence is itself an important part of this story. For people already navigating the emotional and physical demands of fertility treatment, the stakes of any perceived risk feel enormous. A survey of women considering or undergoing fertility treatment found that higher levels of medical mistrust were significantly associated with vaccine hesitancy and with concerns about vaccine side effects.²⁸ During the Omicron wave, patients with the greatest medical mistrust were also the most likely to worry that COVID vaccination would increase their risk of miscarriage or harm their treatment outcomes.²⁹

This is not a character flaw; it is a predictable response when emotionally high-stakes medical decisions collide with incomplete early information and amplified online speculation. The tragedy is that some people delayed vaccination to protect their fertility, inadvertently exposing themselves to a virus that poses a genuine threat to reproductive health, particularly for men and for pregnant women in the third trimester. The irony is thick: the data now show that the vaccine is not only neutral for fertility, it actively protects pregnant women and their babies from the very harms people feared.